Profilo
Daniel Tesfa worked as a Medical Director at Swedish Orphan Biovitrum AB, Chief Medical Officer at Vivesto AB, and Country Medical Manager at Roche AB. He also worked as the Head of Oncology & Hematology at Bayer AB from 2018 to 2020.
Dr. Tesfa holds a doctorate degree from Karolinska Institutet and the University of Lund.
Precedenti posizioni note di Daniel Tesfa
| Società | Posizione | Fine |
|---|---|---|
Bayer AB
Bayer AB Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Corporate Officer/Principal | 01/01/2020 |
Roche AB
Roche AB Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical goods | Corporate Officer/Principal | - |
| SWEDISH ORPHAN BIOVITRUM AB | Direttore Tecnico/Scientifico/R&S | - |
| VIVESTO AB | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Daniel Tesfa
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Società collegate
| Aziende private | 6 |
|---|---|
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vivesto AB
Vivesto AB Pharmaceuticals: GenericHealth Technology Develops cancer drugs based on nanotechnology for human and veterinary use | Health Technology |
Roche AB
Roche AB Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical goods | Health Technology |
Bayer AB
Bayer AB Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Health Technology |
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
















